Abstract
Background: Recent studies have uncovered that vitexin compound B-1 (VB-1) can protect neurons against hypoxia/reoxygenation (H/R)-induced oxidative injury through suppressing NOX4 expression.
Objective: The aims of this study are to investigate whether VB-1 can protect the rat brain against ischemia/ reperfusion (I/R) injury and whether its effect on NOX4 expression is related to modulation of certain miRNAs expression.
Methods: Rats were subjected to 2 h of cerebral ischemia followed by 24 h of reperfusion to establish an I/R injury model, which showed an increase in neurological deficit score and infarct volume concomitant with an upregulation of NOX4 expression, increase in NOX activity, and downregulation of miR-92b.
Results: Administration of VB-1 reduced I/R cerebral injury accompanied by a reverse in NOX4 and miR-92b expression. Similar results were achieved in a neuron H/R injury model. Next, we evaluated the association of miR-92b with NOX4 by its mimics in the H/R model. H/R treatment increased neurons apoptosis concomitant with an upregulation of NOX4 and NOX activity while downregulation of miR-92b. All these effects were reversed in the presence of miR-92b mimics, confirming the function of miR-92b in suppressing NOX4 expression.
Conclusion: We conclude the protective effect of VB-1 against rat cerebral I/R injury through a mechanism involving modulation of miR-92b/NOX4 pathway.
Keywords: Ischemic stroke, ischemia/reperfusion injury, miR-92b, NADPH oxidase, vitexin compound B-1, cerebral injury.
Graphical Abstract
[http://dx.doi.org/10.1016/j.pneurobio.2017.01.001] [PMID: 28110083]
[http://dx.doi.org/10.1016/S1474-4422(16)00114-9] [PMID: 27180033]
[http://dx.doi.org/10.2174/1871527311312050015] [PMID: 23469845]
[http://dx.doi.org/10.1007/s00210-015-1125-2] [PMID: 25920934]
[http://dx.doi.org/10.1158/1078-0432.CCR-09-0661] [PMID: 19671865]
[http://dx.doi.org/10.1016/j.fct.2010.03.052] [PMID: 20381571]
[http://dx.doi.org/10.1002/ptr.2021] [PMID: 17262892]
[http://dx.doi.org/10.1016/j.phymed.2009.12.010] [PMID: 20096549]
[http://dx.doi.org/10.1002/pca.1348] [PMID: 21858882]
[http://dx.doi.org/10.1021/np400222v] [PMID: 23742617]
[http://dx.doi.org/10.4062/biomolther.2015.128] [PMID: 26535084]
[http://dx.doi.org/10.1142/S0192415X13500845] [PMID: 24228599]
[http://dx.doi.org/10.3892/mmr.2017.6114] [PMID: 28098903]
[http://dx.doi.org/10.1038/srep19266] [PMID: 26763934]
[http://dx.doi.org/10.1002/ptr.4841] [PMID: 22976055]
[http://dx.doi.org/10.1016/j.ejphar.2012.10.017] [PMID: 23099258]
[http://dx.doi.org/10.1007/s00210-014-1006-0] [PMID: 24947869]
[http://dx.doi.org/10.1038/nrd.2016.246] [PMID: 28209991]
[http://dx.doi.org/10.1016/j.ejphar.2015.09.042] [PMID: 26420356]
[http://dx.doi.org/10.1007/s00210-013-0922-8] [PMID: 24081521]
[http://dx.doi.org/10.1042/CS20140084] [PMID: 24943094]
[http://dx.doi.org/10.1161/01.STR.29.5.1037] [PMID: 9596255]
[http://dx.doi.org/10.1016/j.molimm.2017.02.020] [PMID: 28288411]
[PMID: 27648122]
[http://dx.doi.org/10.1016/j.fitote.2016.09.011] [PMID: 27693342]
[http://dx.doi.org/10.1016/j.phymed.2015.11.003] [PMID: 26902402]
[http://dx.doi.org/10.1016/j.freeradbiomed.2021.05.028] [PMID: 34029693]
[http://dx.doi.org/10.1002/fsn3.1567] [PMID: 32566174]
[http://dx.doi.org/10.1016/j.biopha.2020.109849] [PMID: 31972356]
[http://dx.doi.org/10.1139/cjpp-2021-0034] [PMID: 33915055]
[http://dx.doi.org/10.1155/2021/9921982] [PMID: 34257823]
[http://dx.doi.org/10.1155/2018/4785089] [PMID: 30627560]
[http://dx.doi.org/10.17219/acem/104556] [PMID: 32011832]
[http://dx.doi.org/10.3892/etm.2021.9930] [PMID: 33791008]
[http://dx.doi.org/10.3390/cancers7030855] [PMID: 26305257]
[http://dx.doi.org/10.1016/j.biopha.2020.109860] [PMID: 32000043]
[http://dx.doi.org/10.2147/NDT.S293611] [PMID: 34234438]
[http://dx.doi.org/10.1007/978-3-030-04615-6_8] [PMID: 31407062]
[http://dx.doi.org/10.1089/ars.2012.4797] [PMID: 22937798]
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.115.05645] [PMID: 26283043]